Globus Medical vs Insulet
Globus Medical reported revenue of $2.9 billion in fiscal 2025, about the same as Insulet's $2.7 billion in fiscal 2025. Globus Medical's revenue grew 16.6% in its latest year, and Insulet's grew 30.7%. Globus Medical had an operating margin of 16.3%, against 17.5% at Insulet. Free cash flow was $589 million at Globus Medical and $378 million at Insulet.
Side by side
| Globus Medical | Insulet | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $2.9B | $2.7B |
| Revenue growth | 16.6% | 30.7% |
| Revenue growth a year, last 5 years | 30.1% | 24.5% |
| Gross margin | 67.4% | 71.6% |
| Operating margin | 16.3% | 17.5% |
| Net margin | 18.3% | 9.1% |
| Free cash flow | $589M | $378M |
| Free cash flow margin | 20.0% | 13.9% |
| Return on capital | 11.0% | 20.4% |
| Net debt to EBITDA | −0.7x | 0.4x |
| Dividends and buybacks | $300M | $60M |
| Change in diluted share count | −0.6% | −2.7% |
| Last close | $81.83 | $149.26 |
| P/E at the last close | 21.0× | 28.0× |
| Insider trades, last 12 months | sold $17.5 million | bought $2.9 million, sold $602,397 |
| Piotroski F-score | 9 of 9 | 7 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Globus MedicalInsulet
Operating margin
Percent of revenue
Globus MedicalInsulet
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Globus MedicalInsulet
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Globus Medical and Insulet pages.